ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020
Endobronchial aspergilloma-a comprehensive literature review with focus on diagnosis and treatment modalities.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 20 citations in OpenAlex.
- Endobronchial Aspergillosis Presenting as an Isolated Airway Lesion in an Immunocompromised Patient.Respirology case reports · 2026Article
- Pulmonary aspergilloma due toIDCases · 2026Article
- Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026Review
- Aspergilloma Presenting as Endobronchial Mass.Tuberculosis and respiratory diseases · 2026Article
- A Rare Case of Allergic Bronchopulmonary Aspergillosis With Endobronchial Aspergilloma Causing Total Lung Collapse.Cureus · 2025Article
- Persistent cough with unexplained endobronchial mass.World journal of pediatrics : WJP · 2025Article
- Coexistence of endobronchial aspergilloma, pulmonary embolism, and lung cancer: a case report.Frontiers in oncology · 2025Article
- Endobronchial aspergilloma mimicking metastatic recurrence in a patient with metastatic sarcomatoid renal cell carcinoma: a case report.Respiratory medicine case reports · 2025Article
- Recovery of temperature to normal may indicate the best time for surgery in patients with lung cancer complicated by a lung abscess: A case report.Oncology letters · 2024Article
- Article
- Obstructive Pneumonia Associated with Endobronchial Aspergilloma: Successful Treatment with Interventional Bronchoscopy and Antifungals.Internal medicine (Tokyo, Japan) · 2022Article
- An Unusual and Rare Presentation of Pulmonary Aspergillosis: Endobronchial Aspergilloma.Case reports in infectious diseases · 2021Article
- Lung cancer mimickers - a case series of seven patients and review of the literature.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endobronchial aspergilloma (EBA) is a rare manifestation of pulmonary infection with Aspergillus spp. Comprised of hyphae, mucus, and cellular debris, the massive fungus overgrowth can lead to obstructive pneumonitis in large airways, manifesting as cough, dyspnea, hemoptysis, or weight loss. The aim of this paper is to review the literature on endobronchial aspergilloma to further elucidate this disease entity and to classify it as a non-invasive form of pulmonary aspergillosis. A descriptive analysis was performed on articles on PubMed database that contained the key word "endobronchial aspergilloma." A total of 28 cases were obtained. Four articles were excluded as they were not available in the English format. Although EBA is extremely rare, it should be considered in the differential diagnosis of endobronchial masses in immunocompromised patients. There is a potential for the disease entity to progress to tracheobronchitis and fulminant respiratory failure. As such, early detection with bronchoscopy, biopsy, and culture is required to confirm pulmonary aspergillosis. Current treatment regimens remain to be optimized, though piecemeal resection of the mycetoma with bronchoscopic techniques with the addition of systemic antifungals and their combinations has been reported as efficacious.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.